Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy

With recent advances in oncology, immune checkpoint inhibitors (ICIs) have become a milestone in immuno-oncology. Unfortunately, although ICIs have demonstrated improved clinical efficacy in a broad spectrum of cancers, many patients do not respond to this newer therapy. As a result, it is crucial t...

Descripción completa

Detalles Bibliográficos
Autores principales: Parosanu, Andreea, Stanciu, Ioana Miruna, Pirlog, Cristina, Orlov Slavu, Cristina, Cotan, Horia, Iaciu, Cristian, Popa, Ana Maria, Olaru, Mihaela, Moldoveanu, Oana, Catalin, Baston, Nitipir, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703028/
https://www.ncbi.nlm.nih.gov/pubmed/36451642
http://dx.doi.org/10.7759/cureus.30821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703028/
https://www.ncbi.nlm.nih.gov/pubmed/36451642
http://dx.doi.org/10.7759/cureus.30821

Ejemplares similares